Scor credit ratings are pared
Article Abstract:
Scor S.A.'s credit ratings were lowered to triple-B-plus from single-A-minus by Standard and Poor's. The reinsurance firm said it would attempt to raise capital by spinning off its life reinsurance business.
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 2003
User Contributions:
Comment about this article or add new information about this topic:
Scor first-half profit doubled on lower costs and provisions
Article Abstract:
Scor S.A.'s net profits doubled during the 2003 first half period. The company, which was helped by lower costs and provisions, posted 42 million euros ($45.7 million) in net profits for the period.
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 2003
User Contributions:
Comment about this article or add new information about this topic:
Entire life unit may be sold; A.M. best cuts credit rating
Article Abstract:
Scor S.A. is considering divesting its life insurance unit as part of a corporate restructuring. Scor's credit rating was also lowered to B++ from single-A-minus.
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 2003
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Slow going for investors. Labour pains. A labour-friendly president gets tough on strikers and wins points with big business
- Abstracts: Labour pains. A labour-friendly president gets tough on strikers and wins points with big business. Hyundai Motor, union reach tentative deal
- Abstracts: Interbrew chief realigns officers. Picanol is shadowed by controversy. InBev is facing Belgian Review on disclosures
- Abstracts: U.S., North Korea trade demands. North Korea says it will declare its nuclear-weapons capabilities. Seoul seeks help of China to end Korean deadlock
- Abstracts: Aventis refuses to yield to Sanofi: CEO dismisses hope for a friendly deal, plans asset split-off. Alnylam, Ribopharma to merge